Detalles de la búsqueda
1.
Gain of Chromosome 5q Predicts a Favorable Prognosis in Localized Renal Cell Carcinoma.
Cancer Invest
; 42(1): 97-103, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38314786
2.
Thioredoxin 1 (Trx1) is associated with poor prognosis in clear cell renal cell carcinoma (ccRCC): an example for the crucial role of redox signaling in ccRCC.
World J Urol
; 40(3): 739-746, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34859284
3.
Prognostic Impact of Membranous/Nuclear Epidermal Growth Factor Receptor Localization in Clear Cell Renal Cell Carcinoma.
Int J Mol Sci
; 22(16)2021 Aug 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34445451
4.
Evaluation of the prognostic role of co-morbidities on disease outcome in renal cell carcinoma patients.
World J Urol
; 38(6): 1525-1533, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31520111
5.
The VENUSS prognostic model to predict disease recurrence following surgery for non-metastatic papillary renal cell carcinoma: development and evaluation using the ASSURE prospective clinical trial cohort.
BMC Med
; 17(1): 182, 2019 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31578141
6.
Microvascular and lymphovascular tumour invasion are associated with poor prognosis and metastatic spread in renal cell carcinoma: a validation study in clinical practice.
BJU Int
; 121(1): 84-92, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28803448
7.
Partial nephrectomy versus radical nephrectomy for clinical localised renal masses.
Cochrane Database Syst Rev
; 5: CD012045, 2017 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28485814
8.
Risk factors and model for predicting toxicity-related treatment discontinuation in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Cancer
; 122(3): 411-9, 2016 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26540173
9.
The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study.
Lancet Oncol
; 16(3): 293-300, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25681967
10.
The contemporary role of ablative treatment approaches in the management of renal cell carcinoma (RCC): focus on radiofrequency ablation (RFA), high-intensity focused ultrasound (HIFU), and cryoablation.
World J Urol
; 32(3): 597-605, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24700308
11.
CD70 is Consistently Expressed in Primary and Metastatic Clear Cell Renal Cell Carcinoma.
Clin Genitourin Cancer
; 22(2): 347-353, 2024 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38195301
12.
Deletions of chromosomes 3p and 14q molecularly subclassify clear cell renal cell carcinoma.
Cancer
; 119(8): 1547-54, 2013 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23335244
13.
Metastatic non-clear cell renal cell carcinoma treated with targeted therapy agents: characterization of survival outcome and application of the International mRCC Database Consortium criteria.
Cancer
; 119(16): 2999-3006, 2013 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23696129
14.
Smoking negatively impacts renal cell carcinoma overall and cancer-specific survival.
Cancer
; 118(7): 1795-802, 2012 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21997347
15.
Gain of chromosome 8q is associated with metastases and poor survival of patients with clear cell renal cell carcinoma.
Cancer
; 118(23): 5777-82, 2012 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22605478
16.
Prognostic value of microvascular invasion in predicting the cancer specific survival and risk of metastatic disease in renal cell carcinoma: a multicenter investigation.
J Urol
; 187(2): 418-23, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22177164
17.
Effect of the heat shock protein HSP27 on androgen receptor expression and function in prostate cancer cells.
World J Urol
; 30(3): 327-31, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22362414
18.
Pathological and genetic markers improve recurrence prognostication with the University of California Los Angeles Integrated Staging System for patients with clear cell renal cell carcinoma.
Eur J Cancer
; 168: 68-76, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35461012
19.
Prognostication in localised renal cell carcinoma.
Lancet Oncol
; 16(6): 603-4, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25979596
20.
p53 is functionally inhibited in clear cell renal cell carcinoma (ccRCC): a mechanistic and correlative investigation into genetic and molecular characteristics.
J Cancer Res Clin Oncol
; 147(12): 3565-3576, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34499221